期刊文献+

缬沙坦和氨氯地平对老年原发性高血压病患者左心室和血管内皮舒张功能及胰岛素水平的影响 被引量:5

Influence of valsartan and amlodipine on the left ventricular diastolic function,endothelium function and serum insuline level in aged hyperpietic patients
下载PDF
导出
摘要 目的:观察缬沙坦和氨氯地平对老年原发性高血压的降压作用及对左心室舒张功能,血管内皮舒张功能,胰岛素抵抗的改善作用. 方法:选择1~2级老年高血压患者40例,随机分为缬沙坦治疗组和氨氯地平治疗组,分别治疗12周,每周测血压2次,观察两组患者治疗前后血压、心率及胰岛素敏感性的变化,左心室舒张功能以及内皮依赖性血管舒张功能的变化. 结果和结论:缬沙坦组和氨氯地平组均可有效地降低1~2级老年原发性高血压患者的血压,改善左心室舒张功能、胰岛素抵抗及内皮依赖性血管舒张功能. Objective : To observe the effect of valsartan and amlodipine on the reduction of blood pressure in aged hyperpietic patients, as well as on the improvement of left ventricular diastolic function, endothelium function and insuline resistence. Methods: We divided 40 cases of aged hypertension patients ( 1 to 2 grade) into Valsartan and Amlodipine groups at random, giving valsartan 80-160 mg or amlodipine 5-10 mg, respectively, for 12 weeks as a treating period. We measured the blood pressure twice a week, observed the differences of blood pressure and heart rate before and after the treatment, as well as the changes of insuline sensitivity, left ventricular diastolic function and endothelium vascular disatolic function. Results and Conclusion: Both valsartan and amlodipine can effectivly reduce the blood pressure of aged hypertension patients ( 1 insuline resistance and endothelium dependent to 2 grade). They can also improve the diastolic function, vascular diastolic function.
出处 《医学研究生学报》 CAS 2005年第12期1102-1104,1107,共4页 Journal of Medical Postgraduates
基金 南京市人事局科研基金资助项目(批准号:RB9802)
关键词 高血压 原发性 缬沙坦 氨氯地平 左心室舒张功能 血管内皮功能 胰岛素 Hypertension Primary Valsartan Amlodipine Left ventricular diastolic function Endothelium function Insuline
  • 相关文献

参考文献9

二级参考文献30

  • 1龚艳艳,尹中君.莫索尼定治疗难治性高血压[J].中国新药与临床杂志,2004,23(12):907-908. 被引量:1
  • 2张启高,江时森,陈锐华,宫剑滨,徐军,王立军,彭永平.马来酸氨氯地平治疗原发性高血压疗效观察[J].医学研究生学报,2004,17(12):1090-1092. 被引量:4
  • 3刘国仗.胰岛素抵抗及其检测方法[J].中华心血管病杂志,1996,24(1):3-4. 被引量:125
  • 4[1]Malacco E, Vari N, Cauanov S et al. A randvmized, double-blind, active-controlled, paralledl-group comparison of valsartan and amlodipine in the treatment of lsolated systolic hypertension in elderly patients: the val-syst study[J]. Clin Ther, 2003, 25(11): 2765-2780.
  • 5[2]White WB, Saunders E, Nove CKRJ et al. Comparative efficacy and safety of nisoldipine extended-release and amlodipine (CESNA-Ⅲ study) in African American patients with hypertension[J]. Am J Hypertens, 2003, 16(99): 739-745.
  • 6[3]Waeker B, Borges ET, Christeler P et al. Amlodipine compared to nitrendipine in hypertensive patients: The effects or toleration in relationship to the outset of action[J]. Cardiology, 1992, 80(Suppl 1): S 46-48.
  • 7[4]Neaton JD, Grimm PH Jr, Prineas RJ et al. Treatment of mild hypertension study, Final results[J]. JAMA, 1993, 270(6):713-724.
  • 8He J, Klag MJ, Caballero B, et al. Plasma insulin levels and incidence of hypertension in African Americans and whites. Arch Intern Med, 1999, 159:498-503.
  • 9Monti LD, Sandoli EP, Phan VC, et al. A sensitive and reliable method for assaying true human insulin without interaction with human proinsulin-like molecules. Acta Diabetol, 1995, 32:57-63.
  • 10Roder ME, Porte D Jr, Schwartz RS, et al. Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab, 1998, 83:604-608.

共引文献2172

同被引文献55

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部